Literature DB >> 2674559

Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group.

K Bendtzen1, K Buschard, M Diamant, T Horn, M Svenson.   

Abstract

Recent experiments indicate a central role of macrophages (M phi), and natural killer (NK) cells, and their products IL-1, IL-6 and TNF alpha in autoimmune endocrine diseases. Intermediate levels of IL-1 alpha/beta inhibit the function of pancreatic beta-cells and thyrocytes, an effect potentiated by TNF alpha. In contrast, low levels of IL-1 potentiate the secretion of insulin and thyroid hormones, and intermediate levels of IL-6 double glucose-induced insulin production by beta-cells. Intermediate and high levels of IL-1 and IL-6 are cytotoxic to normal beta-cells. IL-1 induces IL-6 in isolated islets and in thyrocytes. The cytokines may play a role in the physiological regulation of endocrine functions, for instance during conditions of stress. The genes for TNF alpha and -beta, both located in the MHC region, and IL-6 are polymorphic, and specific alleles may control the amount of cytokine produced. Specific TNF alpha/beta alleles may be in linkage disequilibrium with HLA alleles known to be positively or negatively associated with endocrine and other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674559

Source DB:  PubMed          Journal:  Lymphokine Res        ISSN: 0277-6766


  10 in total

1.  Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease.

Authors:  J Brynskov; M B Hansen; C Reimert; K Bendtzen
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells.

Authors:  Junfei Jin; Devadoss J Samuvel; Xiaoming Zhang; Yanchun Li; Zhongyang Lu; Maria F Lopes-Virella; Yan Huang
Journal:  Mol Immunol       Date:  2011-10-26       Impact factor: 4.407

3.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

Authors:  J C Pickup; M B Mattock; G D Chusney; D Burt
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

4.  Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.

Authors:  R M Ruggeri; D Villari; A Simone; R Scarfi; M Attard; F Orlandi; G Barresi; F Trimarchi; M Trovato; S Benvenga
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

5.  Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM.

Authors:  A Cox; A M Gonzalez; A G Wilson; R M Wilson; J D Ward; C M Artlett; K Welsh; G W Duff
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

Review 6.  Th17 cells in human disease.

Authors:  Laura A Tesmer; Steven K Lundy; Sujata Sarkar; David A Fox
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 7.  Cytokines and autoimmunity.

Authors:  M G Cavallo; P Pozzilli; R Thorpe
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

8.  The Association Between Circulating Trans Fatty Acids and Thyroid Function Measures in U.S. Adults.

Authors:  Xiaoqian Wang; Fengjuan Jiang; Wenqing Chen; Hui Yuan; Yuan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-08       Impact factor: 6.055

9.  Autoimmune thyroid disorders.

Authors:  M A Iddah; B N Macharia
Journal:  ISRN Endocrinol       Date:  2013-06-26

Review 10.  Radiation-induced inflammation and autoimmune diseases.

Authors:  Rasoul Yahyapour; Peyman Amini; Saeed Rezapour; Mohsen Cheki; Abolhasan Rezaeyan; Bagher Farhood; Dheyauldeen Shabeeb; Ahmed Eleojo Musa; Hengameh Fallah; Masoud Najafi
Journal:  Mil Med Res       Date:  2018-03-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.